We are live on
!
Find out more
BE
Bonness Enterprises Portfolio holdings
AUM
$310M
1-Year Est. Return
24.22%
This Fund
S&P 500
This Quarter
Est. Return
+8.34%
1 Year Est. Return
+24.22%
3 Year Est. Return
+94.56%
5 Year Est. Return
+137.52%
10 Year Est. Return
+441.57%
AUM
$225M
AUM Growth
+$12.1M
(+5.7%)
Cap. Flow
-$3.14M
Cap. Flow
% of AUM
-1.4%
Top 10 Holdings %
Top 10 Hldgs %
69.79%
Holding
41
New
1
Increased
–
Reduced
6
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE HealthCare
GEHC
|
+$288K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CAJ
Canon, Inc.
CAJ
|
+$1.59M |
| 2 |
Microsoft
MSFT
|
+$1.2M |
| 3 |
GE Aerospace
GE
|
+$285K |
| 4 |
Thermo Fisher Scientific
TMO
|
+$234K |
| 5 |
Stryker
SYK
|
+$53.1K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 39.55% |
| 2 | Healthcare | 28.22% |
| 3 | Technology | 20.11% |
| 4 | Consumer Staples | 3.66% |
| 5 | Industrials | 3.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Progressive
PGR
$122B
| $82.1M | 36.54% |
573,653
| – | – |
|
|
2
Stryker
SYK
$130B
| $19.4M | 8.66% |
68,130
-200
| -0.3% | -$53.1K |
|
|
3
Microsoft
MSFT
$3.64T
| $12M | 5.33% |
41,500
-4,700
| -10% | -$1.2M |
|
4
Apple
AAPL
$4.49T
| $9.06M | 4.03% |
54,940
| – | – |
|
5
Merck
MRK
$315B
| $7.39M | 3.29% |
69,500
| – | – |
|
|
6
Thermo Fisher Scientific
TMO
$214B
| $6.33M | 2.82% |
10,985
-415
| -4% | -$234K |
|
7
Johnson & Johnson
JNJ
$611B
| $6.02M | 2.68% |
38,838
-200
| -0.5% | -$32.3K |
|
8
AbbVie
ABBV
$435B
| $5.88M | 2.62% |
36,900
| – | – |
|
9
Cisco
CSCO
$457B
| $4.32M | 1.93% |
82,700
| – | – |
|
|
MRSH
10
Marsh
MRSH
$92B
| $4.25M | 1.89% |
25,500
-200
| -0.8% | -$33.3K |
|
11
Intel
INTC
$458B
| $4.25M | 1.89% |
129,950
| – | – |
|
12
Nucor
NUE
$59B
| $4.24M | 1.89% |
27,435
| – | – |
|
13
Unilever
UL
$138B
| $3.95M | 1.76% |
67,591
| – | – |
|
14
IBM
IBM
$215B
| $3.88M | 1.73% |
29,564
| – | – |
|
15
Applied Materials
AMAT
$409B
| $3.84M | 1.71% |
31,300
| – | – |
|
16
Bristol-Myers Squibb
BMY
$133B
| $3.76M | 1.68% |
54,300
| – | – |
|
17
Emerson Electric
EMR
$85.9B
| $3.75M | 1.67% |
43,000
| – | – |
|
18
Pfizer
PFE
$142B
| $3.53M | 1.57% |
86,608
| – | – |
|
19
Abbott
ABT
$185B
| $3.31M | 1.47% |
32,700
| – | – |
|
20
United Parcel Service
UPS
$90.7B
| $2.9M | 1.29% |
14,950
| – | – |
|
21
Agilent Technologies
A
$39.4B
| $2.48M | 1.1% |
17,900
| – | – |
|
22
Procter & Gamble
PG
$337B
| $2.44M | 1.09% |
16,400
| – | – |
|
23
Oracle
ORCL
$404B
| $2.39M | 1.06% |
25,700
| – | – |
|
24
Corning
GLW
$127B
| $1.99M | 0.89% |
56,400
| – | – |
|
25
GSK
GSK
$103B
| $1.88M | 0.84% |
52,960
| – | – |
|
Similar funds
IPW
TL
RGC
IR
TWM
PH
CCG
FI
Bonness Enterprises's Q1 2023 Portfolio in Review
As of Q1 2023, Bonness Enterprises held 41 positions worth $225M, up 5.7% from $213M the previous quarter. Its ten largest holdings account for 70% of the portfolio.
Trading was light in Q1 2023: portfolio turnover was 4.9%. Bonness Enterprises opened 1 new position and exited 1, leaving the 41-position portfolio largely intact.
By sector, the portfolio is most concentrated in Financials at 40% of assets, up from 38% a quarter earlier, followed by Healthcare and Technology.
- Bonness Enterprises's largest Q1 2023 buy was GE HealthCare: 4,028 shares worth $330K.
- Bonness Enterprises's biggest Q1 2023 reduction was Microsoft, cutting an estimated $1.2M.
- Bonness Enterprises fully exited Canon, Inc. in Q1 2023, selling an estimated $1.59M.
- Bonness Enterprises's ten largest holdings make up 70% of its $225M portfolio in Q1 2023.
- Bonness Enterprises opened 1 new position and closed 1 in Q1 2023.
- Bonness Enterprises's portfolio value rose 5.7% quarter-over-quarter to $225M.
Based on Bonness Enterprises's 13F filing for Q1 2023, filed 19 Apr 2023.